Anti-RELP fusion antibodies, compositions, methods and uses
OwnerCarton Jill, Giles-Komar Jill +2inventors
InventorsCarton Jill, Giles-Komar Jill, Scallon Bernard, Staquet Kimberly
Life of this patent
Estimating the term…
Abstract
The present invention relates to at least one novel anti-RELP fusion antibody, including isolated nucleic acids that encode at least one anti-RELP fusion antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Claims21
At least one isolated mammalian RELP fusion antibody, comprising at least one heavy chain variable region comprising SEQ ID NO:7 and at least one light chain variable region comprising SEQ ID NO:8.
At least one isolated mammalian RELP fusion antibody, comprising at least one heavy chain variable region comprising SEQ ID NO:27 and at least one light chain variable region comprising SEQ ID NO:28.
At least one isolated mammalian RELP fusion antibody, comprising at least one light chain variable region comprising SEQ ID NO:39.
An isolated nucleic acid vector comprising an isolated nucleic acid according to claim 117.
Dependencies are inferred from the claim text.